Machine learning ‐driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy
ConclusionsOur study revealed a number of hub genes and novel pathways to provide potential targets for the treatment of HCM. A stable model was developed, providing an efficient tool for the diagnosis of HCM.
Source: ESC Heart Failure - Category: Cardiology Authors: Shutong Liu,
Peiyu Yuan,
Youyang Zheng,
Chunguang Guo,
Yuqing Ren,
Siyuan Weng,
Yuyuan Zhang,
Long Liu,
Zhe Xing,
Libo Wang,
Xinwei Han Tags: Original Article Source Type: research
More News: Allergy & Immunology | Cardiology | Cardiomyopathy | Genetics | Heart | Heart Failure | Hypertrophic Cardiomyopathy | Learning | Study | Universities & Medical Training